Clinical correlates of Parkinson’s disease metabolic pattern: not only a diagnostic tool
Objective: To define and cross-validate the glucose metabolism abnormalities related to Parkinson's Disease (PD), and to analyze pattern relationship with clinical phenotype Background: In PD,…Characteristics of the amyloid beta networks in Parkinson’s disease patients: a PPMI study
Objective: The impact that amyloid beta (Aβ) accumulation in the brain has on the progression of Parkinson’s disease (PD) pathology is complex and poorly understood…Dissociated longitudinal evolution of limbic serotonergic and striatal dopaminergic and serotonergic pathology in apathetic and non-apathetic patients in early Parkinson’s disease
Objective: To investigate the longitudinal changes in striatal and extra-striatal dopaminergic and serotonergic innervation in apathetic and non-apathetic patients during the five years after the…Cognition-related functional topographies in Parkinson’s disease: Localized loss of the ventral default mode network
Objective: We sought to determine whether functional network abnormalities seen in patients with Parkinson’s disease (PD) and cognitive decline reflect the loss of the default…Progression of nigrostriatal dysfunction in Parkinson’s disease: a longitudinal multimodal PET study
Objective: To investigate the longitudinal course of nigrostriatal metabolic and dopaminergic dysfunction and its impact on symptom severity in Parkinson's disease (PD) patients using a…Cognitive-affective syndrome related to cerebellar hypometabolism secondary to Covid-19 infection : a case report
Objective: To describe a novel case of Covid-19-related cognitive affective syndrome with cerebellar hypometabolism and associated neuropathy. Background: Several Covid-19-related neurological diseases have been described, including…VMAT2 availability in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder
Objective: To use [11C]DTBZ PET imaging to explore vesicular monoamine transporter 2 (VMAT2) availability in Parkinson’s disease (PD) with and without rapid eye movement sleep…Widespread loss of presynaptic terminal marker SV2A in early Huntington’s disease.
Objective: To assess synaptic damage in early stages of Huntington’s disease (HD) in vivo. Background: Synaptic damage has long been suspected to play a major…Comorbid Moyamoya Disease and Parkinson’s disease: A case series
Objective: We report the first case series of comorbid Moyamoya disease (MMD) and Parkinson’s disease (PD). Background: MMD is characterized by angiographic findings of bilateral…Clinical variants of PSP: phenotypical convergence and its relationship with the brain glucose metabolism
Objective: To evaluate the phenotypical convergence phenomena among a cohort of different PSP variants. We also aimed to evaluate the possible correlations of the regional…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 40
- Next Page »